Skip to content

067630.KQ

HLB Life Science Co., Ltd.

KOE · Utilities · Renewable Utilities · KR

KRW 3,280.00
−1.80%
Ask drillr

Year over year

Reported trailing growth

Revenue
-42.1%
EBITDA
—
EBIT
+9.8%
EPS
+52.4%
Free cash flow
+20.9%
Operating cash flow
-10.5%

Forward estimates

Based on analyst estimates

Revenue
—
EBITDA
—
EPS
—

Three-year CAGR

Revenue
-22.8%
EBITDA
—
EBIT
+0.0%
Net income
—
EPS
—
Free cash flow
+18.4%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026